Replies to post #21499 on BioCurex, Inc.(fka BOCX)

[Rich1234]

This is somewhat similar to book publishing. Just licensing a book manuscript to a publisher is usually not enough, unless the manuscript is a preordained blockbuster by famous personalities. Usually, after licensing, the author is required to do hard selling of the book by going to television talk shows and the like. It is not like the book publisher will do everything.

[Gold Seeker]

Rich, you obviously know about sales and probably one of the most important facets of sales is to have a product consumers will want.

For over a year, I have been stating that RECAF is not a test the medical ommunity will desire. What you have with RECAF in its use for men will return a positive for slow growing prostate cancer in huge numbers. By age 70, about 80% of men have enough slow growing prostate cancer cells to show a positive with the PSA test and now the medical experts are saying you should not even administer a PSA test to anyone over 75. Recaf will only make that situation worse.

As for women, 2/3 of the breast cancers are slow growing and should be left alone. What happens when RECAF is used and other tests attempt to locate the cancer, these slow growing cancer cells may be found and patients will want to have them removed. That is not the direction the medical community is moving.

The reality is that the medical community for the past few years is moving away from screening that finds all these cancers where treatment actually does more harm than good.